Fulgent Genetics, Inc.FLGTNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P15
Within normal range
vs 5Y Ago
-0.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -136.08% |
| Q3 2025 | 22.13% |
| Q2 2025 | 0.41% |
| Q1 2025 | -22.68% |
| Q4 2024 | 5.53% |
| Q3 2024 | 9.66% |
| Q2 2024 | 13.27% |
| Q1 2024 | 85.58% |
| Q4 2023 | -70717.29% |
| Q3 2023 | 101.08% |
| Q2 2023 | 20.25% |
| Q1 2023 | 32.09% |
| Q4 2022 | -10484.09% |
| Q3 2022 | -97.25% |
| Q2 2022 | -93.66% |
| Q1 2022 | 33.85% |
| Q4 2021 | -5.28% |
| Q3 2021 | 61.05% |
| Q2 2021 | -62.95% |
| Q1 2021 | 18.15% |
| Q4 2020 | 255.63% |
| Q3 2020 | 2306.17% |
| Q2 2020 | 237.93% |
| Q1 2020 | -367.97% |
| Q4 2019 | -127.10% |
| Q3 2019 | 411.53% |
| Q2 2019 | 116.18% |
| Q1 2019 | -77.16% |
| Q4 2018 | -21.63% |
| Q3 2018 | 15.48% |
| Q2 2018 | 54.38% |
| Q1 2018 | -5.99% |
| Q4 2017 | -39.77% |
| Q3 2017 | -887.33% |
| Q2 2017 | -168.49% |
| Q1 2017 | -82.61% |
| Q4 2016 | 281.15% |
| Q3 2016 | -171.65% |
| Q2 2016 | 257.72% |
| Q1 2016 | 91.63% |